Bronchopulmonary Infection

Also known as: Pneumonia, unspecified organism / Lung inflammation / Pneumonia and influenza &/or pneumonia / Pneumonia / Pneumonia (disorder) / Pneumonia (disorder) [Ambiguous] / Pneumonia NOS / Pneumonia NOS (disorder) / Pulmonitis

Drugs
Drugs and Targets

Drug	Drug Name	Drug Description
DB00438	Ceftazidime	An injected broad-spectrum third-generation cephalosporin beta-lactam antibiotic used to treat or prevent a variety of bacterial infections, including pneumonia, gynecological infections, bone and joint infections, and septicemia, among others.
DB04552	Niflumic acid	A cyclooxygenase-2 inhibitor used to alleviate inflammation, pain, and edema associated with acute and chronic inflammatory conditions, such as rheumatoid arthritis, osteoarthritis, post-operative inflammatory conditions, and physical trauma.

Drug	Drug Name	Target	Type
DB00438	Ceftazidime	Solute carrier family 22 member 6	transporter
DB00438	Ceftazidime	Peptidoglycan synthase FtsI	target
DB00438	Ceftazidime	Penicillin-binding protein 1A	target
DB00438	Ceftazidime	Penicillin-binding protein 1B	target
DB00438	Ceftazidime	Penicillin-binding protein 2	target
DB00438	Ceftazidime	Serum albumin	carrier
DB00438	Ceftazidime	Beta-lactamase Toho-1	target
DB04552	Niflumic acid	Phospholipase A2	target
DB04552	Niflumic acid	Chloride channel protein ClC-Ka	target
DB04552	Niflumic acid	Monocarboxylate transporter 2	transporter
DB04552	Niflumic acid	Monocarboxylate transporter 1	transporter
DB04552	Niflumic acid	Prostaglandin G/H synthase 2	target
DB04552	Niflumic acid	Prostaglandin G/H synthase 1	target
DB04552	Niflumic acid	Cytosolic phospholipase A2	target
DB04552	Niflumic acid	UDP-glucuronosyltransferase 1-9	target
DB04552	Niflumic acid	UDP-glucuronosyltransferase 1-9	enzyme

Drug	Drug Name	Phase	Status	Count